, Leishmaniasis in high-burden countries: an epidemiological update based on data reported in 2014, Wkly. Epidemiol. Rec, vol.91, pp.287-296, 2016.
Therapeutic switching in Leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs, J Parasit Dis, vol.35, pp.104-112, 2011. ,
Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art, Parasitology, vol.145, pp.219-236, 2018. ,
Visceral leishmaniasis treatment outcome and its determinants in northwest Ethiopia, Epidemiol Health, vol.39, p.2017001, 2016. ,
, Int J Environ Res Public Health, vol.7, pp.4267-4277, 2010.
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge, PLoS Negl Trop Dis, vol.11, p.6052, 2017. ,
Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis, Antimicrob. Agents Chemother, vol.58, pp.2608-2613, 2014. ,
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an openlabel, non-inferiority, randomised controlled trial, Lancet, vol.377, pp.477-486, 2011. ,
Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages, Parasitol. Res, vol.115, pp.713-721, 2016. ,
In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity, Antimicrob. Agents Chemother, vol.53, pp.835-838, 2009. ,
Leishmania donovani develops resistance to drug combinations, PLoS Negl Trop Dis, vol.6, p.1974, 2012. ,
Simultaneous multi-parametric analysis of Leishmania and of its hosting mammal cells: A high content imaging-based method enabling sound drug discovery process, Microb. Pathog, vol.88, pp.103-108, 2015. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01433404
Haplotype selection as an adaptive mechanism in the protozoan pathogen Leishmania donovani, Nat Ecol Evol, vol.1, pp.1961-1969, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02107201
Impact of continuous axenic cultivation in Leishmania infantum virulence, PLoS Negl Trop Dis, vol.6, p.1469, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00691462
New insights into experimental visceral leishmaniasis: Real-time in vivo imaging of Leishmania donovani virulence, PLoS Negl Trop Dis, vol.11, p.5924, 2017. ,
Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation, Cell. Microbiol, vol.13, pp.978-991, 2011. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01433560
Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assay, Antimicrob. Agents Chemother, vol.57, pp.2913-2922, 2013. ,
New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource, Sci Rep, vol.5, p.8771, 2015. ,
High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to antileishmanial drug discovery, PLoS Negl Trop Dis, vol.7, p.2154, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01433415
An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans, Mol. Biochem. Parasitol, vol.130, pp.31-42, 2003. ,
In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences, Antimicrob. Agents Chemother, vol.53, pp.3855-3859, 2009. ,
Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes, Antimicrob. Agents Chemother, vol.43, pp.278-282, 1999. ,
Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds, PLoS Negl Trop Dis, vol.4, p.675, 2010. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00696809
Establishment and characterization of a human acute monocytic leukemia cell line (THP-1), Int. J. Cancer, vol.26, pp.171-176, 1980. ,
THP-1 cell line: an in vitro cell model for immune modulation approach, Int. Immunopharmacol, vol.23, pp.37-45, 2014. ,
THP-1 cells as a model for human monocytes, Ann Transl Med, vol.4, p.438, 2016. ,
Monocytes, peripheral blood mononuclear cells, and THP-1 cells exhibit different cytokine expression patterns following stimulation with lipopolysaccharide, Mediators Inflamm, p.697972, 2013. ,
The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line, Nature, vol.500, pp.207-211, 2013. ,
The genomic and transcriptomic landscape of a HeLa cell line, Bethesda), vol.3, pp.1213-1224, 2013. ,
High variability of genomic instability and gene expression profiling in different HeLa clones, Sci Rep, vol.5, p.15377, 2015. ,
Screening out irrelevant cell-based models of disease, Nat Rev Drug Discov, vol.15, pp.751-769, 2016. ,
Whole genome sequencing of live attenuated Leishmania donovani parasites reveals novel biomarkers of attenuation and enables product characterization, Sci Rep, vol.7, p.4718, 2017. ,
Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor, Mol. Biochem. Parasitol, vol.120, pp.33-40, 2002. ,
Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination, Infect. Immun, vol.70, pp.62-68, 2002. ,
Differentiation of Leishmania donovani in host-free system: analysis of signal perception and response, Mol. Biochem. Parasitol, vol.141, pp.99-108, 2005. ,
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness, Nature, vol.537, pp.229-233, 2016. ,
Regulation dynamics of Leishmania differentiation: deconvoluting signals and identifying phosphorylation trends, Mol. Cell Proteomics, vol.13, pp.1787-1799, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01433413
What has proteomics taught us about Leishmania development?, Parasitology, vol.139, pp.1146-1157, 2012. ,
A touch of Zen: post-translational regulation of the Leishmania stress response, Cell. Microbiol, vol.17, pp.632-638, 2015. ,
Leishmania donovani: long-term culture of axenic amastigotes at 37 degrees C, Exp. Parasitol, vol.73, pp.326-334, 1991. ,
A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani, Antimicrob. Agents Chemother, vol.60, pp.3524-3532, 2016. ,
Studies in vitro on infectivity and sensitivity to antileishmanial drugs in New World Leishmania species transfected with the green fluorescent protein, Parasitology, vol.144, pp.1718-1725, 2017. ,
Importance of secondary screening with clinical isolates for anti-Leishmania drug discovery, Sci Rep, vol.8, p.11765, 2018. ,
Comparison of the effects of Leishmania major or Leishmania donovani infection on macrophage gene expression, Infect. Immun, vol.76, pp.1186-1192, 2008. ,
Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment, Infection, vol.41, pp.1177-1182, 2013. ,
A species-specific approach to the use of non-antimony treatments for cutaneous leishmaniasis, Am. J. Trop. Med. Hyg, vol.84, pp.109-117, 2011. ,
Leishmaniasis: treatment updates and clinical practice guidelines review, Curr. Opin. Infect. Dis, vol.28, pp.426-437, 2015. ,
, , vol.9, 2019.
Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis, J. Infect. Dis, vol.195, pp.1846-1851, 2007. ,
Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide, PLoS Negl Trop Dis, vol.8, p.2832, 2014. ,
The enemy within: Targeting host-parasite interaction for antileishmanial drug discovery, PLoS Negl Trop Dis, vol.11, p.5480, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01570238
Achievements, Challenges, and Opportunities in DNA-Encoded Library Research: An Academic Point of View, Chembiochem, vol.18, pp.829-836, 2017. ,
An Integrated Microfluidic Processor for DNA-Encoded Combinatorial Library Functional Screening, ACS Comb Sci, vol.19, pp.181-192, 2017. ,
From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity, Antimicrob. Agents Chemother, vol.60, pp.2822-2833, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01299756